You are here

dalbavancin

Durata's anti-infective drug shows efficacy, safety -FDA panel

Yahoo/Zacks.com

Mon, 03/31/14 - 04:39 pm

advisory panels

3 Upcoming FDA Meetings You Should be Watching

Motley Fool

Sun, 03/23/14 - 09:45 am

Cubist Pharmaceuticals

tedizolid phosphate

3 Biotechs With Major Catalysts Incoming

Motley Fool

Wed, 03/19/14 - 11:22 am

Durata Therapeutics

Durata Therapeutics presents new efficacy review of dalbavancin

The Fly on the Wall

Wed, 10/2/13 - 09:33 am

Durata Therapeutics

skin infections

Durata, with license to Pfizer drug, lays plans for $86M IPO

Fierce Biotech

Fri, 03/23/12 - 12:45 pm